Business · 02/02/2005Updated: 10/17/2026 · 1 min read

FDA Authorizes Emergency Use of Anthrax Vaccine for High-Risk Individuals

The FDA has issued an Emergency Use Authorization for Anthrax Vaccine Adsorbed to protect individuals aged 18-65 at heightened risk of exposure to anthrax due to a potential military emergency, following a declaration of emergency by the Secretary of Health and Human Services.